|
|
Volumn 367, Issue 9519, 2006, Pages 1315-
|
|
Controversies in cardiology
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACENOCOUMAROL;
ANTICOAGULANT AGENT;
TRIFLUSAL;
CLINICAL FEATURE;
CLINICAL TRIAL;
EMBOLISM PREVENTION;
FOLLOW UP;
HEART ATRIUM FIBRILLATION;
HIGH RISK POPULATION;
HUMAN;
LETTER;
MITRAL VALVE STENOSIS;
PATIENT SELECTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TREATMENT OUTCOME;
CONTROLLED CLINICAL TRIAL;
INTERNATIONAL NORMALIZED RATIO;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
THROMBOEMBOLISM;
ANTICOAGULANTS;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
THROMBOEMBOLISM;
|
|
EID: 33646043137
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(06)68570-X Document Type: Letter |
|
Times cited : (3)
|
|
References (5)
|
